Insights

Technological Innovation MindWalk's integration of Bio-Native AI, deep data analytics, and advanced laboratory research positions it as a leader in next-generation biologics discovery, creating opportunities for partnerships in AI-driven therapeutic development.

Expanding Presence Recent office expansions in Texas and the company's rebranding to emphasize its technology-forward approach suggest increased capacity for research collaborations and regional client engagement.

Diverse Product Pipeline With ongoing projects developing AI-designed GLP-1 peptides and a comprehensive service offering across biologics discovery and engineering, MindWalk is well-positioned to attract biotech firms seeking innovative antibody and peptide solutions.

Growth Potential Although currently generating $10M to $25M in revenue with a modest $7M funding, targeted outreach to smaller biotech companies and pharmaceutical partners could unlock further revenue streams via joint development projects.

Strategic Collaborations Partnering with larger biotech and pharma companies seeking cutting-edge biologics discovery expertise presents a significant sales opportunity for MindWalk's end-to-end solutions and modular SaaS offerings.

Similar companies to MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)

MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) Tech Stack

MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) uses 8 technology products and services including html5media, Amazon Kinesis, GDPR, and more. Explore MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s tech stack below.

  • html5media
    Audio, Video, Graphics
  • Amazon Kinesis
    Big Data Processing
  • GDPR
    Certificates
  • Amazon Elastic Container Registry (ECR)
    Containerization
  • Amazon EventBridge
    IT Infrastructure & Operations Management
  • Slick
    Javascript Libraries
  • Elasticsearch
    Search Engines
  • HTTP/3
    Web & Portal Technology

MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s Email Address Formats

MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) uses at least 2 format(s):
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) Email FormatsExamplePercentage
FLast@immunoprecise.comJDoe@immunoprecise.com
71%
First@immunoprecise.comJohn@immunoprecise.com
18%
First.Last@immunoprecise.comJohn.Doe@immunoprecise.com
8%
FMiddleLast@immunoprecise.comJMichaelDoe@immunoprecise.com
3%
FLast@mindwalkai.comJDoe@mindwalkai.com
100%

Frequently Asked Questions

Where is MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s headquarters located?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s main headquarters is located at 823 Congress Avenue Austin, Texas 78701 United States. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s phone number?

Minus sign iconPlus sign icon
You can contact MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s official website and social media links?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s official website is mindwalkai.com and has social profiles on LinkedInCrunchbase.

What is MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s SIC code NAICS code?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) have currently?

Minus sign iconPlus sign icon
As of June 2026, MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) has approximately 87 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Ceo And President, Mindwalk Holdings Corp: J. B.Chief Business Officer: T. L.Chief Financial Officer: R. S. A.. Explore MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s employee directory with LeadIQ.

What industry does MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) belong to?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) operates in the Biotechnology Research industry.

What technology does MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) use?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s tech stack includes html5mediaAmazon KinesisGDPRAmazon Elastic Container Registry (ECR)Amazon EventBridgeSlickElasticsearchHTTP/3.

What is MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s email format?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s email format typically follows the pattern of FLast@immunoprecise.com. Find more MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) email formats with LeadIQ.

How much funding has MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) raised to date?

Minus sign iconPlus sign icon
As of June 2026, MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) has raised $7M in funding. The last funding round occurred on Jan 27, 2025 for $7M.

When was MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) founded?

Minus sign iconPlus sign icon
MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) was founded in 1989.

MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)

Biotechnology ResearchTexas, United States51-200 Employees

MindWalk formerly known as IPA (ImmunoPrecise Antibodies).

MindWalk is a global biologics discovery company integrating Bio-Native AI, deep data, and advanced lab research to help accelerate discovery and development of therapeutic, anti-drug, and diagnostic antibodies, peptide-based therapies, vaccines, and beyond. We deliver end-to-end solutions spanning target exploration, discovery, engineering, characterization, production, and humanization—available as full-service partnerships, existing-asset co-development, or modular SaaS access. We partner with leading biotech and pharmaceutical organizations, applying our unified biointelligence ecosystem to advance next-generation biologics for human health.

Section iconCompany Overview

Headquarters
823 Congress Avenue Austin, Texas 78701 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1989
Employees
51-200

Section iconFunding & Financials

  • $7M

    MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) has raised a total of $7M of funding over 10 rounds. Their latest funding round was raised on Jan 27, 2025 in the amount of $7M.

  • $10M$25M

    MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $7M

    MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies) has raised a total of $7M of funding over 10 rounds. Their latest funding round was raised on Jan 27, 2025 in the amount of $7M.

  • $10M$25M

    MindWalk Corp. (formerly IPA ImmunoPrecise Antibodies)'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.